Highly diluted medication reduces tissue parasitism and inflammation in mice infected by Trypanosoma cruzi

[1]  S. F. D. Moraes,et al.  Moderate physical exercise reduces parasitaemia and protects colonic myenteric neurons in mice infected with Trypanosoma cruzi , 2013, International journal of experimental pathology.

[2]  G. Dias,et al.  Evolution of infection in mice inoculated by the oral route with different developmental forms of Trypanosoma cruzi I and II. , 2013, Experimental parasitology.

[3]  Jian Yu,et al.  Role of Apoptosis in Colon Cancer Biology, Therapy, and Prevention , 2013, Current Colorectal Cancer Reports.

[4]  A. Mijares,et al.  Etanercept Induces Low QRS Voltage and Autonomic Dysfunction in Mice with Experimental Chagas Disease , 2013, Arquivos brasileiros de cardiologia.

[5]  D. L. Aleixo,et al.  Causticum hahnemanni, Conium maculatum and Lycopodium clavatum highly diluted medications decreases parasitemia in mice infected by Trypanosoma cruzi , 2012 .

[6]  Gabriela Melo de Oliveira,et al.  Uso da associação de Benznidazol e Espironolactona em camundongos na fase aguda da infecção pelo Trypanosoma cruzi , 2012 .

[7]  É. Ferreira,et al.  Highly diluted medication reduces parasitemia and improves experimental infection evolution by Trypanosoma cruzi , 2012, BMC Research Notes.

[8]  Silvana Marques de Araújo,et al.  Infecção experimental pelo Trypanosoma cruzi em camundongos: influência do exercício físico versus linhagens e sexos , 2012 .

[9]  G. Ippolito,et al.  High-level tolerance to triclosan may play a role in Pseudomonas aeruginosa antibiotic resistance in immunocompromised hosts: evidence from outbreak investigation , 2012, BMC Research Notes.

[10]  Fnu Nagajyothi,et al.  Curcumin treatment provides protection against Trypanosoma cruzi infection , 2012, Parasitology Research.

[11]  Andrew M. Wilson,et al.  Aerobic physical exercise in women with Chagas disease , 2011 .

[12]  S. M. de Araújo,et al.  Different forms of administration of biotherapy 7dH in mice experimentally infected by Trypanosoma cruzi produce different effects , 2011, Homeopathy.

[13]  Silvana Marques de Araújo,et al.  Parâmetros para avaliação clínica de camundongos em experimentação , 2011 .

[14]  J. P. Ferrando,et al.  Actuación de enfermería en las intoxicaciones por cardiotóxicos en un servicio de urgencias hospitalario , 2011 .

[15]  Hudson Hübner França,et al.  Desafio em saúde pública: tratamento etiológico da doença de Chagas na fase crônica , 2011 .

[16]  S. Andrade.  Apoptose e sua importancia no curso da infecção pelo Trypanosoma cruzi , 2011 .

[17]  O. Leeser.  Constitution and constitutional treatment , 2011, Homeopathy.

[18]  R. Cuman,et al.  Canova medication modifies parasitological parameters in mice infected with Trypanosoma cruzi. , 2010, Experimental parasitology.

[19]  L. Fichera,et al.  Trypanosoma cruzi: biological characterization of a isolate from an endemic area and its susceptibility to conventional drugs. , 2010, Experimental parasitology.

[20]  Max Jean de Ornelas Toledo,et al.  Preinfection aerobic treadmill training improves resistance against Trypanosoma cruzi infection in mice. , 2009, Applied physiology, nutrition, and metabolism = Physiologie appliquee, nutrition et metabolisme.

[21]  M. Gomes,et al.  Changes of RAPD profile of Trypanosoma cruzi II with Canova and Benznidazole , 2008, Homeopathy.

[22]  A. Henriques-Pons,et al.  Fas ligand-dependent inflammatory regulation in acute myocarditis induced by Trypanosoma cruzi infection. , 2007, The American journal of pathology.

[23]  O. Tapia,et al.  The chemotherapy of chagas' disease: an overview. , 2005, Mini reviews in medicinal chemistry.

[24]  S. Cimerman,et al.  Parasitologia Humana e seus fundamentos gerais , 2005 .

[25]  N. Nikitakis,et al.  The role of apoptosis in oral disease: mechanisms; aberrations in neoplastic, autoimmune, infectious, hematologic, and developmental diseases; and therapeutic opportunities. , 2004, Oral surgery, oral medicine, oral pathology, oral radiology, and endodontics.

[26]  S. G. Andrade,et al.  Oral transmission of Chagas disease: importance of Trypanosoma cruzi biodeme in the intragastric experimental infection. , 2002, Revista do Instituto de Medicina Tropical de Sao Paulo.

[27]  R. Gazzinelli,et al.  Pivotal role of interleukin-12 and interferon-gamma axis in controlling tissue parasitism and inflammation in the heart and central nervous system during Trypanosoma cruzi infection. , 2001, The American journal of pathology.

[28]  Silvana Marques de Araújo,et al.  Programa ACHEI: Atenção ao Chagásico com Educação Integral no Município de Maringá e Região Noroeste do Paraná, Brasil The ACHEI Program: Chagas' Disease Awareness through Comprehensive Education in the Municipality of Maringá, Northwest Paraná, Brasil , 2000 .

[29]  J. Gama-Rodrigues,et al.  Life cycle of Trypanosoma cruzi (Y strain) in mice. , 1999, Revista do Hospital das Clinicas.

[30]  A. Stoppani.  [The chemotherapy of Chagas disease]. , 1999, Medicina.

[31]  J. Coura,et al.  [Comparative controlled study on the use of benznidazole, nifurtimox and placebo, in the chronic form of Chagas' disease, in a field area with interrupted transmission. I. Preliminary evaluation]. , 1997, Revista da Sociedade Brasileira de Medicina Tropical.

[32]  C. Kitanaka,et al.  Apoptosis in cancer. , 1996, Human cell.

[33]  Ricardo Veronesi,et al.  Doenças infecciosas e parasitárias , 1991 .

[34]  Z. Brener.  Therapeutic activity and criterion of cure on mice experimentally infected with Trypanosoma cruzi. , 1962, Revista do Instituto de Medicina Tropical de Sao Paulo.

[35]  J. C. P. Dias.  Doença de Chagas , 1945 .